日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Identification of FAT4 as a positive prognostic biomarker in DLBCL by comprehensive genomic analysis

通过全面的基因组分析鉴定出FAT4是弥漫性大B细胞淋巴瘤(DLBCL)的阳性预后生物标志物。

Lv, Liyang; Qi, Xiaolong; Wang, Chun; Ma, Yutong; Nie, Yuling; Abulaiti, Renaguli; Zhang, Fang; Shi, Qiping; Kou, Zhen; Abuduer, Muhebaier; Zhai, Shunsheng; An, Li; Huang, Qin; Gu, Zailinuer; Ou, Qiuxiang; Liu, Hong; Wang, Zengsheng; Shao, Yang; Sun, Zhenzhu; Fu, Ling; Wang, Xiaomin; Mao, Min; Li, Yan

[Distribution and prognostic value of LymphGen genotyping in patients with diffuse large B-cell lymphoma]

[淋巴基因分型在弥漫性大B细胞淋巴瘤患者中的分布及预后价值]

Zhang, F; Renaguli, Abulaiti; Qi, X L; Kou, Z; Zhai, S S; Tan, W; Muhebaier, Abuduer; Nie, Y L; Li, Y

[Efficacy and safety of high-dose dexamethasone combined with rhTPO for newly diagnosed adults with severe immune thrombocytopenia]

[高剂量地塞米松联合rhTPO治疗新诊断的重度免疫性血小板减少症成人患者的疗效和安全性]

Li, Yan; Huang, Qin; Wang, Chao; Muhebaier; An, Li; Wang, Xiaomin